openPR Logo
Press release

Bovine Mastitis Treatment Market to Reach USD 2.95 Billion by 2031 Driven by Regulatory Shift and Focus on Antibiotic Alternatives

Bovine Mastitis Treatment Market to Reach USD 2.95 Billion

[Rotterdam, May 17, 2025] - The global Bovine Mastitis Treatment Market, currently valued at USD 1.92 billion, is projected to grow at a CAGR of 6.3%, reaching USD 2.95 billion by 2031, according to Clearview Market Insights. This surge is attributed to the increasing demand for residue-free milk, selective antibiotic use, and investment in cow comfort and diagnostics.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-bovine-mastitis-treatment-market/

2024 Industry Milestones:
Rise of Selective Dry Cow Therapy
• Over 50% of EU dairy farms adopt SDCT, supported by culture-based decision tools.
• Zoetis expands global sales of Orbeseal®, a leading internal teat sealant.

On-Farm Mastitis Diagnostics Boom:
• Portable PCR kits launched across 12 countries.
• North American producers report 25% reduction in blanket antibiotic treatments.

Alternative Therapies Gain Ground:
• Probiotic udder health solutions launched in India and Brazil.
• Teat-dip innovations show improved bacterial resistance control.

Executive Insights:
Mastitis is not just a disease-it's a strategic cost center. Controlling it demands smarter decisions, better hygiene, and new therapeutic approaches," said Dr. Marissa Nguyen, Dairy Health Research Lead, Clearview Market Insights.

"Selective dry cow therapy represents the future of mastitis control. With diagnostics in hand, producers can now tailor treatments for safety, sustainability, and profitability," added Lars Andersen, Regional Director, Boehringer Ingelheim Animal Health.

Roadmap to 2031:
• 2025: 40% of mastitis treatments worldwide guided by rapid diagnostics
• 2026: Adoption of residue-free mastitis protocols in 30+ countries
• 2028: Non-antibiotic therapies account for 35% of market revenue
• 2030: Smart milking systems automate mastitis detection and alerting
• 2031: Global dairy trade tied to compliance with selective treatment and withdrawal norms

For more insights, visit https://clearviewmarketinsights.com/

Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

About Clearview Market Insights
Clearview Market Insights provides in-depth intelligence across animal health, diagnostics, and livestock disease management. Our research supports evidence-based decision-making for veterinary pharma, dairy processors, and producers worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bovine Mastitis Treatment Market to Reach USD 2.95 Billion by 2031 Driven by Regulatory Shift and Focus on Antibiotic Alternatives here

News-ID: 4021607 • Views:

More Releases from ClearView Market Insights

Global Clamps Market to Reach USD 7.4 Billion by 2031, Driven by Industrial Growth and Medical Demand
Global Clamps Market to Reach USD 7.4 Billion by 2031, Driven by Industrial Grow …
[London, 6 November 2025] - Clearview Market Insights (CVMI) predicts that the global clamps market will rise from USD 5.1 billion in 2024 to USD 7.4 billion in 2031, with a CAGR of 5.4%. Growth is driven by increasing industrial activity, expansion in construction, and greater adoption in automotive and medical sectors. "Clamps are essential tools across industries, ensuring precision, safety, and efficiency in both manufacturing and healthcare applications," said
Global Circulating Tumor Cells Market to Reach USD 12.6 Billion by 2031, Driven by Liquid Biopsy Innovations and Precision Oncology
Global Circulating Tumor Cells Market to Reach USD 12.6 Billion by 2031, Driven …
[Boston, 5 October 2025] - Clearview Market Insights (CVMI) predicts that the global circulating tumor cells market will increase from USD 5.4 billion in 2024 to USD 12.6 billion by 2031, with a compound annual growth rate of 12.7%. The growth is fueled by the demand for minimally invasive cancer diagnostics and the expanding role of CTCs in personalized treatment approaches. Request Sample: https://clearviewmarketinsights.com/report-details/global-circulating-tumor-cells-market/ "Circulating tumor cell analysis is redefining cancer
Global Cerebrospinal Fluid (CSF) Management Market to Reach USD 5.39 Billion by 2031, Driven by Neurosurgical Advancements and Increasing Hydrocephalus Cases
Global Cerebrospinal Fluid (CSF) Management Market to Reach USD 5.39 Billion by …
[London, 04 October 2025] - Clearview Market Insights (CVMI) forecasts that the global cerebrospinal fluid (CSF) management market will increase from USD 2.43 billion in 2024 to USD 5.39 billion by 2031, with a compound annual growth rate (CAGR) of 12.1%. Rising neurological disorder rates, aging populations, and innovations in neurocritical care technologies are driving market expansion. Request Sample: https://clearviewmarketinsights.com/report-details/global-cerebrospinal-fluid-management-market/ "Modern CSF management solutions are transforming the treatment landscape for hydrocephalus,
Global Chromatography Syringe Market to Reach USD 1.96 Billion by 2031, Driven by Growth in Analytical Testing and Automation.
Global Chromatography Syringe Market to Reach USD 1.96 Billion by 2031, Driven b …
[Chicago, 08 October 2025] - Clearview Market Insights (CVMI) predicts that the global chromatography syringe market will increase from USD 1.03 billion in 2024 to USD 1.96 billion by 2031, with a CAGR of 9.5%. The rising demand is due to growing pharmaceutical research, food safety testing, and environmental monitoring. "Chromatography syringes are the backbone of precise analytical testing, ensuring accuracy and reliability in industries where quality matters most," said

All 5 Releases


More Releases for Mastitis

Mastitis Market Trends & Forecast to 2034
The Mastitis Market is expanding steadily due to rising mastitis prevalence in dairy cattle, increased livestock healthcare spending, and growing adoption of advanced diagnostic and therapeutic solutions. As dairy productivity becomes a global priority, demand for mastitis treatment, prevention products, and rapid diagnostics continues to grow. Below is a full breakdown including key players, segmentation, industry updates, and growth drivers. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/51962 1. What Is
Bovine Mastitis Market Is Booming So Rapidly | Neogen, Vetoquinol, Dechra
The "Bovine Mastitis Market" intelligence report, just published by USD Analytics, covers a micro-level study of important market niches, product offers, and sales channels. To determine market size, potential, growth trends, and competitive environment, the Bovine Mastitis Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured Zoetis,
Bovine Mastitis Market to Witness Stunning Growth | Elanco, Ceva, Virbac
A new business intelligence report released by USD Analytics with title "Global Bovine Mastitis Market Report 2030 " has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy. The Global Bovine Mastitis Market Report offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary
Bovine Mastitis Market: Current Trends and Future Prospects
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031. • CAGR: 6.3% • Current Market Size: USD 0.54 Billion • Forecast Growing Region: APAC • Largest Market: North America • Projection Time: 2021- 2031 • Base Year: 2021 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988 Bovine mastitis, an inflammatory condition of the mammary gland in dairy cows, poses
Global Bovine Mastitis Market: Prevalence, Challenges, and Opportunities
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031. • CAGR: 6.3% • Current Market Size: USD 0.54 Billion • Forecast Growing Region: APAC • Largest Market: North America • Projection Time: 2021- 2031 • Base Year: 2021 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988 Bovine mastitis is a prevalent and economically significant disease affecting dairy cattle worldwide.
Emerging Therapies and Innovations in the Bovine Mastitis Market
Bovine mastitis, a common and costly disease affecting dairy cattle, continues to be a significant challenge for the dairy industry worldwide. It is characterized by inflammation of the udder tissue, leading to reduced milk production, decreased milk quality, and increased treatment costs. The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022